Worst performer was IES:Invinity Energy, dropping 21% as people took profits following the recent surge. I guess it was bound to happen.
SBTX:SkinBioTherapeutics shares began trading again after they completed the fraud investigation. They ended up 16% down, but at one point in the week were 37% down, so this isn't bad.
HPOW:H-Power suffered a similar fate to IES, dropping 12% after recent strong gains.
Most of my losses were in my ISA this week, with big drops for HPOW:H-Power, IES:Invinity Energy and SBTX:SkinBioTherapeutics, with the drop in IES reducing potential profits by £104.
The rise is looking more like a blip along a steady decline.
Back below the trend line
It was monthly investment time. I bought 106 shares in ESTC:European Smaller Companies Trust at 232.9611p costing £248.17 and 35 shares in BPM:BP Marsh & Partners at 699.5p costing £244.83. I've bought as many ESTC as I want now, but will continue with BPM for a few more months.
HPOW:H-Power suffered a similar fate to IES, dropping 12% after recent strong gains.
THX:Thor Explorations was the worst hit of my gold miners, dropping 6%. Most of them were down this week, but not by that much.
Share of the Week is shared between GAW:Games Workshop and SBRE:Sabre Insurance, as both climbed 5% and were my only big risers this week.
Here's the ISA and shares portfolio after week 46 of year 11.
| Weekly Change | |||
| Cash | £109.73 | +£0 | |
| Portfolio cost | £116,490.29 | +£0 | |
| Portfolio sell value (bid price-commission) | £31,531.48 | (-72.9%) | -£1,259.89 |
| Potential profits | £351.52 | -£104.52 | |
| Yr 11 Dividends | £86.83 | +£0 | |
| Yr 11 Interest | £1.57 | +£0 | |
| Yr 11 Profit from sales | £873.14 | +£0 | |
| Yr 11 proj avg monthly profit | £82.86 | (1.1%) | -£1.84 |
| Total Dividends | £12,574.90 | +£0 | |
| Total Interest | £10.14 | +£0 | |
| Total Profit from sales | £18,433.41 | +£0 | |
| Average monthly cash profit | £232.52 | (3.2%) | -£0.41 |
| (Sold stocks profit + Dividends - Fees / Months) |
Most of my losses were in my ISA this week, with big drops for HPOW:H-Power, IES:Invinity Energy and SBTX:SkinBioTherapeutics, with the drop in IES reducing potential profits by £104.
The rise is looking more like a blip along a steady decline.
Back below the trend line
The SIPP looks like this after week 550 overall and week 30 of year 11.
| Weekly Change | ||||
| Cash | £814.15 | -£467.92 | ||
| Portfolio cost | £160,213.80 | +£493.00 | ||
| Portfolio sell value (bid price - commission) | £89,598.87 | (-44.1%) | -£251.52 | |
| Potential profits | £10,452.05 | +£234.41 | ||
| Yr 11 Dividends | £1.432.66 | +£25.08 | ||
| Yr 11 Interest | £12.26 | +£0 | ||
| Yr 11 Profit from sales | £9,397.72 | +£0 | ||
| Yr 11 proj avg monthly profit | £1,547.77 | (18.8%) | -£49.62 | |
| Total Dividends | £19,652.86 | +£25.08 | ||
| Total Interest | £32.96 | +£0 | ||
| Total Profit from sales | £34,064.23 | +£0 | ||
| Average monthly cash profit | £409.71 | (5.0%) | -£0.55 |
It was monthly investment time. I bought 106 shares in ESTC:European Smaller Companies Trust at 232.9611p costing £248.17 and 35 shares in BPM:BP Marsh & Partners at 699.5p costing £244.83. I've bought as many ESTC as I want now, but will continue with BPM for a few more months.
Portfolio value only dropped £251 and potential profits actually went up £234 and I got a £25 dividend from GCP:GCP Infrastructure Investments.
Still tantalisingly close to the injection line
Still below the trend line.
Hoping I can stay above £400 until August when I clear out some of my magic formula shares, hopefully for lots of profit.
There was an encouraging presentation from JLP:Jubilee Metals about their Molefe mine this week. It got me all excited in JLP again, but I'm not making the mistake of buying more shares. Every time I do that, the share price drops even further. I am optimistic it will turn around some time this summer when they can show production is increasing. That will be a game changer for my performance in both accounts. It's just taking a very, very long time. I need to keep reminding myself that I've been in this position with JLP before, but have made £1,700 profit in my SIPP and a massive £13,183 in my ISA, so this has been one of my best ever shares. There is hope!
Still tantalisingly close to the injection line
Still below the trend line.
Hoping I can stay above £400 until August when I clear out some of my magic formula shares, hopefully for lots of profit.
There was an encouraging presentation from JLP:Jubilee Metals about their Molefe mine this week. It got me all excited in JLP again, but I'm not making the mistake of buying more shares. Every time I do that, the share price drops even further. I am optimistic it will turn around some time this summer when they can show production is increasing. That will be a game changer for my performance in both accounts. It's just taking a very, very long time. I need to keep reminding myself that I've been in this position with JLP before, but have made £1,700 profit in my SIPP and a massive £13,183 in my ISA, so this has been one of my best ever shares. There is hope!
No comments:
Post a Comment